Advertisement

Topics

ReNeuron Group plc Company Profile

01:30 EST 15th December 2018 | BioPortfolio

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our stem cell technologies into non-therapeutic areas such as drug discovery - our ReNcell product.We have proprietary stem cell technologies which we believe confer significant advantages over competitor technologies, in terms of our ability to generate stable cell lines with the characteristics necessary for commercial exploitation

Location

10 Nugent Rd Surrey Research Park
Guildford,
Surrey
GU2 7AF
United Kingdom

Contact

Phone: 44 (0)1483 302560
Fax: 44 (0)1483 534864
Email: info@reneuron.com


News Articles [686 Associated News Articles listed on BioPortfolio]

ReNeuron Group (RENE) - US exclusivity deal - more than non-dilutive cash

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron ended FY18 with a healthy cash balance and the 11 July announcement of an exclusivity agreement worth up to US$5m wi...

ReNeuron Group (RENE) - Exosomes rise further

Edison Investment Research - Pharmaceutical & healthcare - ReNeuron Group: ReNeuron’s capital markets day highlighted the potential for the company’s exosome nanomedicine platform to be a ...

ReNeuron to resume discussions with other potential suitors as US pharma group backs out

The unnamed group’s decision not to progress to a definitive licensing agreement had nothing to do with ReNeuron’s technology, the company said

'All systems go' with ReNeuron Group Plc looking to treat first PISCES III patient shortly

Michael Hunt, chief financial officer at ReNeuron Group Plc (LON:RENE), tells Proactive's Andrew Scott a Phase IIb clinical trial of their potentially breakthrough CTX cell treatment for stroke will...

ReNeuron pens deal with undisclosed spec pharmaco

ReNeuron Group PLC licensed an undisclosed US specialty pharmaco exclusive global rights (excluding China) to its human retinal progenitor cells (hRPC) technology and therapeutic programs.

ReNeuron signs retinal stem cell exclusivity agreement

ReNeuron Group Plc (LON:RENE) has inked a deal worth up to US$5mln ahead of potentially licensing out its ground-breaking its hRPC retinal stem cell technology and therapeutic programmes. CFO Mich...

ReNeuron will begin clinical trial shortly; upbeat on potential deals

The cell technology group said the first of a group of 110 patients taking part in PICSE III will be enrolled soon

ReNeuron’s CTX stem cell platform could be used to fight cancer

ReNeuron thinks CTX could be reprogrammed and used to produce new non-donor-specific cell lines, including NK and T-Cells – the cells that can be modified to attack cancer cells

PubMed Articles [1747 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

Isolation and exploitation of minority: Game theoretical analysis.

We investigate various group-size distributions occurring in a situation where each group's resource is exposed to appropriation by other groups. The amount of appropriation depends on the size differ...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The role of group cohesion in a group-based behavioral weight loss intervention.

Behavioral weight loss interventions are often delivered in groups. Group cohesion may enhance program attendance and, thereby, weight loss. In this secondary analysis, our goals were to: (1a) assess ...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [4119 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Ultrasound and Exercises in Knee Osteoarthritis

The aim of this investigation is to compare the effects of continuous (CUS) and pulsed (PUS) ultrasound associated with a program of exercises on pain, range of motion, muscle strength, fu...

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

The T2T Study of RA Based on SSDM

This study evaluate the Smart System of Disease Management(SSDM)to improve the treat-to-target(T2T) and the safety of drug in the treatment of rheumatoid(RA). All participants will be ...

Companies [1642 Associated Companies listed on BioPortfolio]

ReNeuron

ReNeuron stem cell transplantation biotechnology for brain cell therapeutics to promote recovery of function.

ReNeuron Group plc

ReNeuron Group plc is a leading player in the stem cell field, using human somatic stem cells to develop leading edge therapies for neurodegenerative and other diseases. We are also leveraging our ste...

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

More Information about "ReNeuron Group plc" on BioPortfolio

We have published hundreds of ReNeuron Group plc news stories on BioPortfolio along with dozens of ReNeuron Group plc Clinical Trials and PubMed Articles about ReNeuron Group plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ReNeuron Group plc Companies in our database. You can also find out about relevant ReNeuron Group plc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record